X-group (possible homology)

4272 Nqo5-like

Ligands and drugs

927
Member domains
12
with ligand contacts (≤ 4 Å)
1.3% of members
17
with DrugDomain annotations
1.8% of members
2
with a DrugBank compound
0.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

4
Proteins with classified ligands
3
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Organic acids and derivatives20.63.28×not tested
Lipids and lipid-like molecules10.42.28×not tested
Homogeneous metal compounds21.91.03×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00157—NADH1
DB02210HEZHexane-1,6-Diol1

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION3
8Q1S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate2
CAmetalCALCIUM ION2
MNmetalMANGANESE (II) ION2
ZMPS-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] tetradecanethioate2
COmetalCOBALT (II) ION1
HEZHEXANE-1,6-DIOL1